Bioventus's total assets for Q1 2025 were $691.41M, a decrease of -5.02% from the previous quarter. BVS total liabilities were $505.94M for the fiscal quarter, a -6.71% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.